- JP-listed companies
- Balance sheet
【JP:4892】Balance sheet
Market cap
¥5.1B
P/E ratio
-5.6x
Cyfuse develops 3D tissues and organs made entirely from human cells for regenerative medicine, drug discovery, and medical device applications.
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Cash and cash equivalents | - | 2,073 | 2,413 | 4,437 | 3,874 | 3,053 | 3,727 |
| Total cash & short-term investments | - | 2,073 | 2,413 | 4,437 | 3,874 | 3,053 | 3,727 |
| Inventories | - | 17 | 37 | 30 | 35 | 37 | 46 |
| Total current assets | - | 2,152 | 2,559 | 4,565 | 3,987 | 3,240 | 3,934 |
| Property, plant and equipment, net | - | 33 | 27 | 189 | 170 | 142 | 155 |
| Total non-current assets | - | 44 | 88 | 250 | 227 | 278 | 332 |
| Total assets | - | 2,196 | 2,646 | 4,815 | 4,215 | 3,518 | 4,266 |
| Short-term debt | - | 50 | 129 | 467 | 550 | 508 | 485 |
| Long-term debt, current | - | 23 | 72 | 78 | 18 | 18 | 185 |
| Total current liabilities | - | 207 | 386 | 683 | 666 | 649 | 866 |
| Total non-current liabilities | - | 440 | 360 | 363 | 345 | 327 | 642 |
| Total liabilities | - | 647 | 746 | 1,046 | 1,011 | 976 | 1,508 |
| Retained earnings | - | -1,170 | -923 | -1,397 | -1,986 | -2,858 | -3,622 |
| Stockholders' equity | 1,779 | 1,549 | 1,900 | 3,770 | 3,203 | 2,542 | 2,758 |